NASDAQ:HALO | EBITDA | HALOZYME THERAPEUTICS, INC.

Complete source-backed ebitda history.

Available history
2009-12-31 to 2026-06-30
Data captured

Historical EBITDA

DateEBITDA
2026-06-30$292.15M
2026-03-31$188.74M
2025-12-31-$89.59M
2025-09-30$220.62M
2025-06-30$205.14M
2025-03-31$144.22M
2024-12-31$178.15M
2024-09-30$165.8M
2024-06-30$119.84M
2024-03-31$97.99M
2023-12-31$103.97M
2023-09-30$90.98M
2023-06-30$97.26M
2023-03-31$56.42M
2022-12-31$77.07M
2022-09-30$85.29M
2022-06-30$35.16M
2022-03-31$76.45M
2021-12-31$57.31M
2021-09-30$76.29M
2021-06-30$93.85M
2021-03-31$51.47M
2020-12-31$78.42M
2020-09-30$41.1M
2020-06-30$30.36M
2020-03-31-$2.37M
2019-12-31-$31.02M
2019-09-30-$23.54M
2019-06-30-$12.98M
2019-03-31$3.96M
2018-12-31$519,000.00
2018-09-30-$24.87M
2018-06-30-$19.47M
2018-03-31-$23.15M
2017-12-31$126.42M
2017-09-30$8.58M
2017-06-30-$24.88M
2017-03-31-$26.92M
2016-12-31-$21.93M
2016-09-30-$22.04M
2016-06-30-$21.12M
2016-03-31-$15.68M
2015-12-31$5.92M
2015-03-31-$13.49M
2014-12-31-$3.39M
2014-03-31-$24.82M
2013-12-31-$20.99M
2013-03-31-$18.2M
2012-12-31-$4.12M
2012-03-31-$14.9M
2011-12-31-$18.18M
2011-03-31-$9.33M
2010-12-31-$17.54M

Annual EBITDA

DateEBITDA
2025-12-31$480.4M
2024-12-31$561.74M
2023-12-31$348.66M
2022-12-31$274.02M
2021-12-31$278.9M
2020-12-31$147.54M
2019-12-31-$63.54M
2018-12-31-$66.94M
2017-12-31$83.16M
2016-12-31-$80.8M
2015-12-31-$25.78M
2014-12-31-$61.27M
2013-12-31-$79.21M
2012-12-31-$52.55M
2011-12-31-$18.74M
2010-12-31-$52.75M
2009-12-31-$57.01M